These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16324896)

  • 1. Psychopathology in never-treated schizophrenia.
    Tirupati SN; Padmavati R; Thara R; McCreadie RG
    Compr Psychiatry; 2006; 47(1):1-6. PubMed ID: 16324896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapyramidal symptoms in unmedicated schizophrenia.
    McCreadie RG; Srinivasan TN; Padmavati R; Thara R
    J Psychiatr Res; 2005 May; 39(3):261-6. PubMed ID: 15725424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight and psychopathology in never-treated schizophrenia.
    Tirupati S; Padmavati R; Thara R; McCreadie RG
    Compr Psychiatry; 2007; 48(3):264-8. PubMed ID: 17445521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations of attitudes toward antipsychotic drugs with insight and objective psychopathology in schizophrenia.
    Rocca P; Crivelli B; Marino F; Mongini T; Portaleone F; Bogetto F
    Compr Psychiatry; 2008; 49(2):170-6. PubMed ID: 18243890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients.
    Ritsner M; Maayan R; Gibel A; Strous RD; Modai I; Weizman A
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):267-73. PubMed ID: 15163435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The structure of Antonovsky's sense of coherence in patients with schizophrenia and its relationship to psychopathology.
    Bengtsson-Tops A; Brunt D; Rask M
    Scand J Caring Sci; 2005 Sep; 19(3):280-7. PubMed ID: 16101857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
    Savilla K; Kettler L; Galletly C
    Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community dysfunction in schizophrenia: rate-limiting factors.
    Bozikas VP; Kosmidis MH; Kafantari A; Gamvrula K; Vasiliadou E; Petrikis P; Fokas K; Karavatos A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):463-70. PubMed ID: 16442195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale.
    Lindenmayer JP; Bossie CA; Kujawa M; Zhu Y; Canuso CM
    Psychopathology; 2008; 41(4):264-70. PubMed ID: 18441528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizophrenia with prominent catatonic features ('catatonic schizophrenia'). II. Factor analysis of the catatonic syndrome.
    Ungvari GS; Goggins W; Leung SK; Gerevich J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):462-8. PubMed ID: 17188791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sociodemographic and clinical factors associated with relapse in schizophrenia.
    Chabungbam G; Avasthi A; Sharan P
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):587-93. PubMed ID: 18081617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
    Chino B; Nemoto T; Fujii C; Mizuno M
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: influence of dual diagnosis.
    Rodriguez-Jimenez R; Aragües M; Jimenez-Arriero MA; Ponce G; Martinez I; Hoenicka J; Rubio G; Palomo T;
    Psychopathology; 2008; 41(1):58-64. PubMed ID: 17975329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].
    Wciórka J; Bembenek A; Hintze B; Kühn-Dymecka A
    Psychiatr Pol; 2006; 40(5):867-84. PubMed ID: 17217232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile.
    Pazvantoglu O; Selek S; Okay IT; Sengul C; Karabekiroglu K; Dilbaz N; Erel O
    Psychiatry Clin Neurosci; 2009 Oct; 63(5):693-700. PubMed ID: 19788631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familiality in a five-factor model of schizophrenia psychopathology: findings from a 16-month follow-up study.
    Ritsner M; Ratner Y; Gibel A; Weizman R
    Psychiatry Res; 2005 Sep; 136(2-3):173-9. PubMed ID: 16098602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP; Spina E; Murray S; Yang R
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia.
    Müller MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1095-100. PubMed ID: 17493732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.